Introduction:

The Controversies in Obesity, Diabetes and Hypertension (CODHy) Meeting: What is it all about?

Itamar Raz and Ram Weiss
Diabetes Care 2008 31: S111-S112. [Extract] [Full Text] [PDF]  

Original Research:

   Section I: Diabetes-What Is New in the Management and Understanding of the Disease?:

Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes: The role of insulin analogs

Paolo Rossetti, Francesca Porcellati, Geremia B. Bolli, and Carmine G. Fanelli
Diabetes Care 2008 31: S113-S120. [Extract] [Full Text] [PDF]  

Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy

Shlomit Shalitin and Moshe Phillip
Diabetes Care 2008 31: S121-S124. [Abstract] [Full Text] [PDF]  

Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage?: An argument in favor

Matthew C. Riddle
Diabetes Care 2008 31: S125-S130. [Extract] [Full Text] [PDF]  

Treatment of Type 2 Diabetes With Combined Therapy: What are the pros and cons?

Massimo Massi-Benedetti and Marco Orsini-Federici
Diabetes Care 2008 31: S131-S135. [Abstract] [Full Text] [PDF]  

Insulin as a First-Line Therapy in Type 2 Diabetes: Should the use of sulfonylureas be halted?

Eberhard Standl and Oliver Schnell
Diabetes Care 2008 31: S136-S139. [Extract] [Full Text] [PDF]  

Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

John C. Pickup and Eric Renard
Diabetes Care 2008 31: S140-S145. [Abstract] [Full Text] [PDF]  

The Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring

Howard A. Wolpert
Diabetes Care 2008 31: S146-S149. [Abstract] [Full Text] [PDF]  

Glycemic Variability: Should we and can we prevent it?

Louis Monnier and Claude Colette
Diabetes Care 2008 31: S150-S154. [Abstract] [Full Text] [PDF]  

Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia

Zvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan, and Markolf Hanefeld
Diabetes Care 2008 31: S155-S160. [Abstract] [Full Text] [PDF]  

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

Marc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren, and Jan A. Ehses
Diabetes Care 2008 31: S161-S164. [Abstract] [Full Text] [PDF]  

Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?

Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer, and Reinhard G. Bretzel
Diabetes Care 2008 31: S165-S169. [Abstract] [Full Text] [PDF]  

   Section II: Diabetes Complications and Hypertension-Novel Insights into Pathophysiology and Management:

NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities

Tamara M. Paravicini and Rhian M. Touyz
Diabetes Care 2008 31: S170-S180. [Abstract] [Full Text] [PDF]  

Possible Role of Oxidative Stress in the Pathogenesis of Hypertension

Antonio Ceriello
Diabetes Care 2008 31: S181-S184. [Abstract] [Full Text] [PDF]  

Does Increased Oxidative Stress Cause Hypertension?

Ehud Grossman
Diabetes Care 2008 31: S185-S189. [Abstract] [Full Text] [PDF]  

Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes

Dick de Zeeuw and Itamar Raz
Diabetes Care 2008 31: S190-S193. [Extract] [Full Text] [PDF]  

Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?

Seema Basi, Pierre Fesler, Albert Mimran, and Julia B. Lewis
Diabetes Care 2008 31: S194-S201. [Extract] [Full Text] [PDF]  

Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low–molecular weight heparin

Edmund J. Lewis and Xiulong Xu
Diabetes Care 2008 31: S202-S207. [Abstract] [Full Text] [PDF]  

Primary Prevention of Cardiovascular Disease in People With Dysglycemia

Cristina Bianchi, Roberto Miccoli, Giuseppe Penno, and Stefano Del Prato
Diabetes Care 2008 31: S208-S214. [Abstract] [Full Text] [PDF]  

Cardiovascular Complications in Diabetes: Targets and interventions

Alin O. Stirban and Diethelm Tschoepe
Diabetes Care 2008 31: S215-S221. [Abstract] [Full Text] [PDF]  

Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?

Harm Wienbergen, Jochen Senges, and Anselm K. Gitt
Diabetes Care 2008 31: S222-S225. [Extract] [Full Text] [PDF]  

Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

Alin O. Stirban and Diethelm Tschoepe
Diabetes Care 2008 31: S226-S228. [Abstract] [Full Text] [PDF]  

Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy, and André Scheen
Diabetes Care 2008 31: S229-S240. [Abstract] [Full Text] [PDF]  

Targets for Intervention in Dyslipidemia in Diabetes

Gerald H. Tomkin
Diabetes Care 2008 31: S241-S248. [Abstract] [Full Text] [PDF]  

Diastolic Pressure in Type 2 Diabetes: Can target systolic pressure be reached without "diastolic hypotension"?

Etty Osher and Naftali Stern
Diabetes Care 2008 31: S249-S254. [Abstract] [Full Text] [PDF]  

Treatment of Diabetic Neuropathy and Neuropathic Pain: How far have we come?

Dan Ziegler
Diabetes Care 2008 31: S255-S261. [Abstract] [Full Text] [PDF]  

   Section III: Obesity-The Rising Epidemic:

Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?

Michael H. Shanik, Yuping Xu, Jan Skrha, Rachel Dankner, Yehiel Zick, and Jesse Roth
Diabetes Care 2008 31: S262-S268. [Abstract] [Full Text] [PDF]  

Treatment Modalities of Obesity: What fits whom?

Vojtech Hainer, Hermann Toplak, and Asimina Mitrakou
Diabetes Care 2008 31: S269-S277. [Abstract] [Full Text] [PDF]  

Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?: What is the controversy about?

Peter M. Nilsson
Diabetes Care 2008 31: S278-S283. [Abstract] [Full Text] [PDF]  

Can Gut Hormones Control Appetite and Prevent Obesity?

Owais B. Chaudhri, Katie Wynne, and Stephen R. Bloom
Diabetes Care 2008 31: S284-S289. [Abstract] [Full Text] [PDF]  

Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis

Francesco Rubino
Diabetes Care 2008 31: S290-S296. [Abstract] [Full Text] [PDF]  

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Guntram Schernthaner and John M. Morton
Diabetes Care 2008 31: S297-S302. [Extract] [Full Text] [PDF]  

Abdominal Fat and Sleep Apnea: The chicken or the egg?

Giora Pillar and Naim Shehadeh
Diabetes Care 2008 31: S303-S309. [Abstract] [Full Text] [PDF]  

Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk

Ram Weiss and Francine Ratner Kaufman
Diabetes Care 2008 31: S310-S316. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.